DOI: 10.4103/ijhqpcs.ijhqpcs_3_26 ISSN: 2666-3848

Hospital-acquired Infections in Indian Corporate Hospitals: A Critical Analysis of Infrastructure, Infection Control, and Antibiotic Resistance

Mohammad Rafique, Yasmeen Khan, Dharmendra Mandarwal, Kailash Verma, Amol Rajendra Gite, Samrat Joshi
Show PDF Cite

Abstract

Background:

Hospital-acquired infections (HAIs) represent a critical threat to patient safety in Indian corporate hospitals despite substantial infrastructure investments.

Objective:

This comprehensive analysis examines the intersecting crises of environmental contamination, antimicrobial resistance, and inadequate infection control practices in Indian corporate hospitals.

Methods:

Synthesis of epidemiological data from surveillance networks, environmental quality assessments, antimicrobial resistance patterns, and systemic analysis of infection control infrastructure across Indian healthcare facilities.

Results:

HAI prevalence ranges from 10% to 20% among admitted patients nationally, with intensive care unit rates demonstrating substantial variation from 4.4% to 83.09% across facilities. Environmental assessment reveals critical contamination: Fine particulate matter (PM2.5) concentrations of 149.41 μg/m 3 representing approximately 10 times World Health Organization guideline values; bacterial contamination of 1389.21 colony-forming units per cubic meter exceeding safety thresholds by factors of 2.8–13.9; and fungal contamination reaching 786.34 colony-forming units per cubic meter, approximately 7.9 times recommended limits. Antimicrobial resistance patterns demonstrate alarming prevalence: Methicillin-resistant Staphylococcus aureus affecting 40%–47% of S. aureus isolates; extended-spectrum beta-lactamase production in 64%–77% of Escherichia coli and Klebsiella pneumoniae; Acinetobacter baumannii demonstrating 89.13% resistance to ceftazidime and 86.08% to ciprofloxacin; and Pseudomonas aeruginosa showing 53.42% imipenem and 43.3%–94.1% meropenem resistance with substantial inter-facility variation. Patients developing HAI experience hospital stays extending 11.96 days longer than matched non-infected controls, with treatment costs two to four times higher. National annual direct medical costs of HAI reach Rs. 28.4–33.8 billion, whereas prevention could generate savings ranging from Rs. 5.7–6.8 billion (assuming 20% prevention rate) to Rs. 19.9–23.7 billion (assuming 70% prevention rate). Systemic examination reveals that HAI persistence reflects institutional failures rather than technical infeasibility, with only 714 hospitals achieving National Accreditation Board for Hospitals and Healthcare Providers accreditation among tens of thousands nationally.

Conclusions:

The HAI crisis in Indian corporate hospitals demands urgent, comprehensive systemic reform encompassing enhanced disinfection infrastructure, antimicrobial stewardship implementation, transparent surveillance reporting, staff training programs, and organizational culture transformation prioritizing patient safety.

More from our Archive